Ligusticum Chuanxiong Rhizome.

Chuanxiong and dang gui form the Fo Shou San pair used for centuries in blood-moving formulas, and both carry ferulic acid and phthalides as shared actives. It is one of the most settled pairings in Chinese herbal formulation.

Both damp platelet aggregation, salvia through tanshinones and chuanxiong through tetramethylpyrazine, and the two are combined in classical circulation formulas. Watch total antiplatelet load when they are used together.

Ferulic acid is a marker constituent of chuanxiong and one of the compounds credited with its effect on platelet activity and vascular tone. Adding it raises the same circulating molecule the herb delivers.

Ginkgolide B antagonises platelet-activating factor while tetramethylpyrazine from chuanxiong damps thromboxane-driven aggregation, so the two stack on normal clotting. Combine with care and account for the total load.

EPA competes with arachidonic acid and shifts eicosanoid output toward the less aggregatory thromboxane A3, which adds to the antiplatelet action of chuanxiong alkaloids. The combined effect on normal clotting is additive.

Nattokinase acts on fibrin directly while chuanxiong acts on platelet aggregation, two different points of the same haemostatic sequence. Stacking them raises the total effect on normal clotting.

Ajoene and related garlic thiosulfinates inhibit platelet fibrinogen receptor activation, which adds to the antiplatelet contribution of chuanxiong.

Salicin is converted to salicylate, which damps thromboxane synthesis, so it layers onto the antiplatelet action of chuanxiong. Account for the combined load on normal clotting.

Chuanxiong rhizome carries ferulic acid and related phenolic acids, which act as one-electron reductants and leave a phenoxyl radical behind. Ascorbate reduces phenoxyl radicals back to the parent phenol in vitro, so the two are routinely formulated together. This is chemistry measured in solution and in cell systems, not a human outcome.

High tocopherol intakes have been reported to reduce platelet aggregation responses, and chuanxiong constituents point the same direction. Stacked, the two push on the same function rather than on separate ones. Anyone already taking something that affects clotting should raise this pairing with a clinician before combining.

Ginger gingerols and chuanxiong alkylpyrazines both have documented effects on platelet aggregation in laboratory work. Combining them is additive on the same pathway, so the practical note is overlap, not enhancement. Flagged so a formulator sees the stack rather than two unrelated botanicals.

Curcuminoids influence platelet aggregation and eicosanoid signalling in vitro, the same broad territory chuanxiong occupies. A blend of the two concentrates activity on one function. Worth stating plainly in a formula that already contains other circulation-directed botanicals.

Quercetin inhibits several platelet activation steps in isolated platelet preparations. Paired with chuanxiong the direction of effect is the same. The evidence here is cell-level and does not establish a measurable difference in people.

Resveratrol reduces platelet aggregation responses in laboratory preparations. Stacking it with chuanxiong loads one mechanism from two directions. Label this as mechanistic overlap rather than a demonstrated combined benefit.

Chuanxiong and panax ginseng appear together in classical multi-herb formulas built around circulation. Ginsenosides also have reported antiplatelet activity in vitro, so the pairing overlaps mechanistically as well as historically. Neither the tradition nor the cell work amounts to a controlled combination trial.

Astragalus is the qi-supporting partner to chuanxiong in a long list of classical formulas, where one is given for circulation and the other for baseline vigour. The pairing is a documented formulation practice with centuries of use. It is a practice record, not a measured interaction.

Licorice is the classical harmoniser added to soften and bind a multi-herb decoction containing chuanxiong. Separately, glycyrrhizin inhibits 11-beta-hydroxysteroid dehydrogenase type 2, which is why sustained high licorice intake raises blood pressure and lowers potassium. Both facts belong on the same row so the pairing is described honestly.

Schisandra and chuanxiong co-occur in traditional tonic formulas, typically at low proportions of the total. The basis is formulation practice recorded in materia medica, not a pharmacokinetic or clinical measurement. Treated as historical pairing only.

Piperine inhibits intestinal and hepatic glucuronidation and several CYP enzymes, which raises circulating levels of phenolic compounds that are otherwise conjugated quickly. Ferulic acid, a documented chuanxiong constituent, is a heavily conjugated phenolic acid. The enhancement is established for other polyphenols and inferred here, so it sits below a measured value.

Magnesium is a physiological calcium antagonist at vascular smooth muscle and contributes to normal vessel tone. Circulation-directed botanicals are commonly formulated alongside it for that reason. The rationale is physiological, and no combination measurement supports a joint figure.

Arginine is the substrate nitric oxide synthase uses to make nitric oxide, the main endothelial vasodilator signal. A botanical aimed at normal circulation and a substrate for the vasodilator pathway act on the same end function by different routes. The shared direction is mechanistic reasoning, not a measured additive effect.

Dietary nitrate is reduced by oral bacteria to nitrite and then to nitric oxide, which lowers blood pressure modestly in controlled studies. Combined with a circulation-directed botanical the direction of effect is the same. Anyone tracking blood pressure should know the two stack rather than cancel.

Catechins and chuanxiong phenolic acids both scavenge reactive species and both undergo extensive phase II conjugation. Co-formulation is common in antioxidant blends. The overlap is chemical and metabolic, and total polyphenol load rather than a specific pairing is what changes.

Vitamin K is the cofactor for gamma-carboxylation of clotting factors II, VII, IX and X, so it supports normal clot formation. A botanical with documented antiplatelet activity pushes the opposite way on haemostasis. The two are not additive, they are opposing inputs to the same system, which is why the pairing is worth stating.